Blog post
Dante Labs selected as Genetic Tests provider for Abu Dhabi Executive Office Employee’s Wellbeing Week
NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, is pleased to announce...
Dante Labs highlights advancements to its drug discovery development program, demonstrating the value of genomic data to drug discovery
NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, highlights significant progress made...
Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert in Europe and the United Arab Emirates (UAE)
Dante Labs is a Global Leader in Genomics and Precision Medicine Mainz is Exclusively Focused on Developing Next Generation Diagnostics...
Dante Labs announces ventures into biosimulation and drug discovery, demonstrating the predictive value of the Dante Platform
NEW YORK, April. 11, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomic information and precision medicine, announces new genomic driven...
Dante Labs establishes the first of its Regional Medical Genomics Boards in Europe made of national and multinational world leaders in genomics
NEW YORK, March. 24, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, announces the establishment of the first...
Dante Genomics partners with Emirates Post to deliver advanced genomic services in UAE
The partnership aims to enable universal access to genomic-driven wellness and longevity June 22, 2022 Emirates Post, the...
Dante Labs announces expansion of its Whole Genome Sequencing test with enhanced and broader offering
NEW YORK, March 3, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today announced the expansion...
Dante Labs Partnering with The Renato Dulbecco Foundation to advance personalized medicines for cancer, COVID-19 and rare diseases
NEW YORK, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Dante Labs, a global leader in genomics and precision medicine, today announced it has...
